( NASDAQ-SMALL:BSTG )

News from Biostage, Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Apr 02, 2018, 08:00 ET Biostage Reports 2017 Financial Results

Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat...


Mar 29, 2018, 16:10 ET Biostage Names Distinguished Children's Hospital Executive James Shmerling to its Board of Directors

Biostage, Inc. (OTCQB: BSTG), a biotechnology company developing bioengineered organ implants to treat life-threatening conditions of the...


Mar 29, 2018, 08:00 ET Biostage awarded SBIR Fast-Track grant to develop Cellspan™ Esophageal Implant (CEI) as a novel treatment for esophageal atresia in pediatric patients

Biostage, Inc. (OTCQB: BSTG), a biotechnology company developing bioengineered organ implants to treat life-threatening conditions of the...


Mar 13, 2018, 07:00 ET Biostage Preclinical Study Results Published in New Report

Biostage, Inc. (OTCQB: BSTG), a biotechnology company developing bioengineered organ implants to treat conditions of the esophagus, bronchus and...


Feb 20, 2018, 07:00 ET Biostage Closes $1 Million Private Placement

Biostage, Inc. (OTCQB: BSTG), a biotechnology company developing bioengineered organ implants to treat conditions of the esophagus, bronchus and...


Feb 06, 2018, 17:08 ET Biostage to Host Conference Call to Provide Business Update

Biostage, Inc. (OTCQB: BSTG), a biotechnology company developing bioengineered organ implants to treat life-threatening conditions of the...


Jan 31, 2018, 07:00 ET Biostage Appoints to its Scientific Advisory Board Christine Finck, MD, Executive Vice President, Surgeon-in-Chief at Connecticut Children's Medical Center

Biostage, Inc. (OTCQB: BSTG), a biotechnology company developing bioengineered organ implants to treat life-threatening conditions of the...


Dec 22, 2017, 07:00 ET Biostage Announces Reverse Stock Split Effective December 22, 2017

Biostage, Inc. (OTCQB: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and...


Oct 12, 2017, 17:08 ET Biostage Conducts Reduction In Force, Evaluating Strategic Alternatives

Biostage, Inc. (OTC-QB: BSTG) ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and...


Oct 06, 2017, 07:25 ET Biostage to Move to OTCQB Marketplace

Biostage, Inc. ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other...


May 23, 2017, 07:05 ET Biostage to Present at the Cell and Gene Exchange 2017

Biostage Inc., (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and...


May 22, 2017, 07:05 ET Biostage Announces Receipt of Nasdaq Listing Determination

Biostage Inc., (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat...


May 11, 2017, 07:00 ET Biostage Reports 2017 First Quarter Financial Results and Provides Business Update

Biostage Inc., (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and...


May 09, 2017, 08:05 ET Dr. Christine Finck of Connecticut Children's Medical Center, Presents Data in Poster Presentation from Collaboration with Biostage at the American Pediatric Surgical Association (APSA) 2017 Annual Meeting

Biostage, Inc., (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and...


May 05, 2017, 08:05 ET Biostage to Host 2017 First Quarter Update Conference Call

Biostage Inc., (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and...


Apr 26, 2017, 07:35 ET Biostage to Participate at the Alliance for Regenerative Medicine's 5th Annual Cell & Gene Therapy Investor Day

Biostage Inc., (Nasdaq: BSTG), ("Biostage" or the "Company), a biotechnology company developing bioengineered organ implants to treat cancers and...


Apr 18, 2017, 08:01 ET Biostage Appoints Stephen F. Badylak DVM, PhD, MD, as Co-Chairman of Scientific Advisory Board

Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat...


Apr 06, 2017, 07:05 ET Biostage Presents Positive Preclincal Data of Cellspan Esophageal Implant at Society For Biomaterials 2017 Annual Meeting and Exposition

Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat...


Mar 28, 2017, 07:05 ET Biostage to Participate at the MassBio 2017 Annual Meeting

Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat...


Mar 16, 2017, 07:05 ET Biostage Promotes Saverio La Francesca, M.D. to President

Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat...


Mar 09, 2017, 07:35 ET Biostage Reports 2016 Financial Results and Provides Business Update

Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and...


Mar 02, 2017, 07:35 ET Biostage to Host Fiscal Year 2016 Update Conference Call

Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and...


Feb 16, 2017, 17:06 ET Biostage Announces Closing of $8.0 Million Public Offering

Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and...


Feb 10, 2017, 07:00 ET Biostage Announces $8.0 Million Public Offering

Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and...


Jan 06, 2017, 07:35 ET Biostage to Present at Biotech Showcase™ 2017

Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and...